Literature DB >> 9383198

Participation of myosin in gliding motility and host cell invasion by Toxoplasma gondii.

J M Dobrowolski1, V B Carruthers, L D Sibley.   

Abstract

Toxoplasma gondii is an obligate intracellular parasite that actively invades mammalian cells using a unique form of gliding motility that critically depends on actin filaments in the parasite. To determine if parasite motility is driven by a myosin motor, we examined the distribution of myosin and tested the effects of specific inhibitors on gliding and host cell invasion. A single 90 kDa isoform of myosin was detected in parasite lysates using an antisera that recognizes a highly conserved myosin peptide. Myosin was localized in T. gondii beneath the plasma membrane in a circumferential pattern that overlapped with the distribution of actin. The myosin ATPase inhibitor, butanedione monoxime (BDM), reversibly inhibited gliding motility across serum-coated slides. The myosin light-chain kinase inhibitor, KT5926, also blocked parasite motility and greatly reduced host cell attachment; however, these effects were primarily caused by its ability to block the secretion of microneme proteins, which are involved in cell attachment. In contrast, while BDM partially reduced cell attachment, it prevented invasion even under conditions in which microneme secretion was not affected, indicating a potential role for myosin in cell entry. Collectively, these results indicate that myosin(s) probably participate(s) in powering gliding motility, a process that is essential for cell invasion by T. gondii.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9383198     DOI: 10.1046/j.1365-2958.1997.5671913.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  81 in total

1.  Time-lapse video microscopy of gliding motility in Toxoplasma gondii reveals a novel, biphasic mechanism of cell locomotion.

Authors:  S Håkansson; H Morisaki; J Heuser; L D Sibley
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

2.  A dibasic motif in the tail of a class XIV apicomplexan myosin is an essential determinant of plasma membrane localization.

Authors:  C Hettmann; A Herm; A Geiter; B Frank; E Schwarz; T Soldati; D Soldati
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

3.  Toxofilin, a novel actin-binding protein from Toxoplasma gondii, sequesters actin monomers and caps actin filaments.

Authors:  O Poupel; H Boleti; S Axisa; E Couture-Tosi; I Tardieux
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

Review 4.  Cytoskeleton of apicomplexan parasites.

Authors:  Naomi S Morrissette; L David Sibley
Journal:  Microbiol Mol Biol Rev       Date:  2002-03       Impact factor: 11.056

5.  Toxoplasma evacuoles: a two-step process of secretion and fusion forms the parasitophorous vacuole.

Authors:  S Håkansson; A J Charron; L D Sibley
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

6.  Identification of a Neospora caninum microneme protein (NcMIC1) which interacts with sulfated host cell surface glycosaminoglycans.

Authors:  Nadine Keller; Arunasalam Naguleswaran; Angela Cannas; Nathalie Vonlaufen; Marianne Bienz; Camilla Björkman; Wolfgang Bohne; Andrew Hemphill
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

Review 7.  Lytic cycle of Toxoplasma gondii.

Authors:  M W Black; J C Boothroyd
Journal:  Microbiol Mol Biol Rev       Date:  2000-09       Impact factor: 11.056

8.  Serine protease inhibitors block invasion of host cells by Toxoplasma gondii.

Authors:  V Conseil; M Soête; J F Dubremetz
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

Review 9.  Biology and mechanism of trypanosome cell motility.

Authors:  Kent L Hill
Journal:  Eukaryot Cell       Date:  2003-04

Review 10.  The structural and functional diversity of Hsp70 proteins from Plasmodium falciparum.

Authors:  Addmore Shonhai; Aileen Boshoff; Gregory L Blatch
Journal:  Protein Sci       Date:  2007-09       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.